ישראל - עברית - Ministry of Health

intervet ( israel) ltd - diclazuril - תרחיף - diclazuril 2.5 mg/ml

ישראל - עברית - Ministry of Health

bioavenir ltd, israel - azithromycin as dihydrate - אבקה להכנת תמיסה מרוכזת לעירוי - azithromycin as dihydrate 500 mg/vial - azithromycin

ישראל - עברית - Ministry of Health

j-c health care ltd - pimozide - טבליה - pimozide 4 mg - pimozide - pimozide - neuroleptic.

ישראל - עברית - Ministry of Health

euromar ltd - diclazuril 2.5 mg/ml - suspension - for the prevention of coccidiosis due to eimeria crandalis and eimeria ovinoidalis in lambs. prevention of coccidiosis due to eimeria bovis and eimeria zuernii in calves.

ישראל - עברית - Ministry of Health

j-c health care ltd - mebendazole - טבליה - mebendazole 100 mg - mebendazole

ישראל - עברית - Ministry of Health

raz pharmaceutics ltd, israel - lidocaine - תמיסה - lidocaine 100 mg / 1 ml - lidocaine

ישראל - עברית - Ministry of Health

raz pharmaceutics ltd, israel - lidocaine hydrochloride - ג'ל - lidocaine hydrochloride 2 %w/w - lidocaine

ישראל - עברית - Ministry of Health

edwards lifesciences (israel) ltd - רופא

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - viread is indicated for the treatment of :1. hiv 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of hiv. 2. chronic hepatitis b in adults with: • compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. • decompensated liver disease

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - viread is indicated for the treatment of :1. hiv 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of hiv. 2. chronic hepatitis b in adults with: • compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. • decompensated liver disease